A randomized clinical trial of outpatient geriatric evaluation and management

A randomized clinical trial of outpatient geriatric evaluation and management
复制标题

DOI:
10.1046/j.1532-5415.2001.49076.x
复制
发表时间:
2001-04-01
影响因子:
6.3
通讯作者:
Urdangarin, CF
Urdangarin, CF
中科院分区:
医学1区
文献类型:
--
作者:
Boult, C;Boult, LB;Urdangarin, CF

文献摘要

被引文献

相似文献

目的:为了测量门诊老年评估和管理(GEM)对高危老年人的功能能力和卫生服务使用的影响,设计:随机临床试验。设置:社区医院的门诊诊所。参与者:以人口为基础的样本,年龄70岁及以上的社区居住医疗保险受益人,他们未来住院的风险很高(N = 568)。干预:综合评估,其次是跨学科的初级care. Measures:功能能力,活动受限的日子,卧床残疾的日子,抑郁症状,死亡率,医疗保险支付,并使用卫生服务。访谈者对参与者的群体状态不知情。意向治疗分析显示,实验参与者丧失功能能力的可能性明显低于对照组(调整后的比值比(aOR)= 0.67,95%置信区间(CI)= 0.47-0.99),在日常活动中经历更多的健康相关限制(aOR = 0.60,95%CI = 0.37-0.96),可能患有抑郁症(aOR = 0.44,95%CI = 0.20-0.94),或在随机化后12 - 18个月内使用家庭医疗服务(aOR = 0.60,95%CI = 0.37-0.92)。死亡率,大多数医疗服务的使用,和总的医疗保险支付两组之间没有显着差异。每人的干预费用为1,350美元。结论:有针对性的门诊GEM减缓了功能衰退。
OBJECTIVES: To measure the effects of outpatient geriatric evaluation and management (GEM) on high-risk older persons' functional ability and use of health services.DESIGN: Randomized clinical trial.SETTING: Ambulatory clinic in a community hospital.PARTICIPANTS: A population-based sample of community-dwelling Medicare beneficiaries age 70 and older who were at high risk for hospital admission in the future (N = 568).INTERVENTION: Comprehensive assessment followed by interdisciplinary primary care.MEASUREMENTS: Functional ability, restricted activity days, bed disability days, depressive symptoms, mortality, Medicare payments, and use of health services. Interviewers were blinded to participants' group status.RESULTS: Intention-to-treat analysis showed that the experimental participants were significantly less likely than the controls to lose functional ability (adjusted odds ratio (aOR) = 0.67, 95% confidence interval (CI) = 0.47-0.99), to experience increased health-related restrictions in their daily activities (aOR = 0.60, 95% CI = 0.37-0.96), to have possible depression (aOR = 0.44, 95% CI = 0.20-0.94), or to use home healthcare services (aOR = 0.60, 95% CI = 0.37-0.92) during the 12 to 18 months after randomization. Mortality, use of most health services, and total Medicare payments did not differ significantly between the two groups. The intervention cost $1,350 per person.CONCLUSION: Targeted outpatient GEM slows functional decline.